Market Research Report
Global Polymerases Market Report, History and Forecast 2017-2028
|Global Polymerases Market Report, History and Forecast 2017-2028|
Published: June 22, 2022
Content info: 130 Pages
Delivery time: 2-3 business days
Due to the COVID-19 pandemic, the global Polymerases market size was value at US$ 345.92 million in 2021 and is forecast to be a readjusted size of US$ 522.94 million by 2028 with a CAGR of 5.9% during the forecast period 2022-2028.
The global main manufacturers of Polymerases include Thermo Fisher Scientific, Merck, New England Biolabs, Promega, Illumina, Agilent Technologies, F. Hoffmann-la Roche, Takara Bio, and QIAGEN N.V., etc. In 2021, the global six largest players have a share approximately 84.33% in terms of revenue.
The North America Polymerases market size was US$ 123.61 million in 2021, while China was about US$ 51.70 million. The proportion of the China was 14.95% in 2021 and it is predicted that the share will reach 16.72% in 2028. As for the Europe Polymerases landscape, Germany is projected to reach US$ 38.61 million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is 5.14% and 1.69% respectively for the next 6-year period.
Fully considering the economic change by the COVID-19, DNA Polymerases accounting for 74.61% of the Polymerases global market in 2021, is projected to value US$ 391.26 million by 2028, growing at a revised 6.0% CAGR from 2022 to 2028. While Academic & Research Institutes segment is altered to a 6.3% CAGR throughout this forecast period and will hold a share about 49.96% in 2028.
The global Polymerases market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Polymerases market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2017-2028.